Skip to main navigation
Galectin Therapeutics Logo
  • Blog
  • What We Do
    • Galectin Proteins
    • Develop Proprietary Compounds
    • Discovery Programs
    • Intellectual Property
  • Our Pipeline
    • Pipeline Overview
    • Development Programs
  • About
    • About Us
    • Leadership
    • Board of Directors
    • Careers
  • Investor Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
    • Stock Information
      • Historic Stock Lookup
      • Analyst Coverage
    • FAQs
    • Email Alert Subscription
  • Learn More
    • About Belapectin
    • About Galectin-3
    • About the NAVIGATE Study
    • Resources
    • Publications
    • News
  • Contact Us
  • What We Do
    • Galectin Proteins
    • Develop Proprietary Compounds
    • Discovery Programs
    • Intellectual Property
  • Our Pipeline
    • Pipeline Overview
    • Development Programs
  • About
    • About Us
    • Leadership
    • Board of Directors
    • Careers
  • Investor Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
    • Stock Information
      • Historic Stock Lookup
      • Analyst Coverage
    • FAQs
    • Email Alert Subscription
  • Learn More
    • About Belapectin
    • About Galectin-3
    • About the NAVIGATE Study
    • Resources
    • Publications
    • News
  • Contact Us
Events and Presentations

Investor Relations

  • Overview
  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Results
  • Stock Information
    • Analyst Coverage
  • FAQs
  • Email Alert Subscription

Financials & Filings

Show all

2020

Fourth Quarter
  • Galectin Therapeutics Reports Fiscal 2020 Financial Results and Provides Business Update
  • Form 10-K

Annual Reports

Title View
  • Add Files
    2020 Form 10-K 734 KB
  • Add Files
    2020 Form 10-K 734 KB
  • Add Files
    2019 Form 10-K 737.2 KB
  • Add Files
    2019 Form 10-K 737.2 KB

Proxy Statements

Filing date View
Oct 19, 2020 View HTML
0001193125-20-271677.pdf
0001193125-20-271677.xls
Oct 17, 2019 View HTML
0001193125-19-268920.pdf
0001193125-19-268920.xls

Form 10-K

Filing date View
Mar 31, 2021 View HTML
0001193125-21-101402.pdf
0001193125-21-101402.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Mar 16, 2020 View HTML
0001193125-20-073907.pdf
0001193125-20-073907.xls
EX-101.INS - XBRL INSTANCE DOCUMENT

Form 10-Q

Filing date View
Nov 09, 2020 View HTML
0001193125-20-288500.pdf
0001193125-20-288500.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 10, 2020 View HTML
0001193125-20-214127.pdf
0001193125-20-214127.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Galectin Therapeutics Logo - Footer

© 2021 Galectin Therapeutics Inc. – All Rights Reserved

  • Compassionate Use Policy
  • Privacy Policy
  • Terms of Use
  • Sitemap

Disclaimer: This site may contain forward-looking information.